Cite
HARVARD Citation
Ji, L. et al. (2022). Selectively targeting disease‐restricted secretogranin III to alleviate choroidal neovascularization. FASEB journal. 36 (1), p. n/a. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Ji, L. et al. (2022). Selectively targeting disease‐restricted secretogranin III to alleviate choroidal neovascularization. FASEB journal. 36 (1), p. n/a. [Online].